Vanhoorelbeke K - Search Results

1

TTP: From empiricism for an enigmatic disease to targeted molecular therapies.

Graça NAG, Joly BS, Voorberg J, Vanhoorelbeke K, Béranger N, Veyradier A, Coppo P. Graça NAG, et al. Among authors: vanhoorelbeke k. Br J Haematol. 2022 Apr;197(2):156-170. doi: 10.1111/bjh.18040. Epub 2022 Feb 10. Br J Haematol. 2022. PMID: 35146746 Free PMC article. Review.

2

ADAMTS13 activity to antigen ratio in physiological and pathological conditions associated with an increased risk of thrombosis.

Feys HB, Canciani MT, Peyvandi F, Deckmyn H, Vanhoorelbeke K, Mannucci PM. Feys HB, et al. Among authors: vanhoorelbeke k. Br J Haematol. 2007 Aug;138(4):534-40. doi: 10.1111/j.1365-2141.2007.06688.x. Epub 2007 Jun 29. Br J Haematol. 2007. PMID: 17608762 Free article.

3

Animal models for thrombotic thrombocytopenic purpura.

Vanhoorelbeke K, De Meyer SF. Vanhoorelbeke K, et al. J Thromb Haemost. 2013 Jun;11 Suppl 1:2-10. doi: 10.1111/jth.12255. J Thromb Haemost. 2013. PMID: 23809106 Free article. Review.

4

ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura - current perspectives and new treatment strategies.

Tersteeg C, Verhenne S, Roose E, Schelpe AS, Deckmyn H, De Meyer SF, Vanhoorelbeke K. Tersteeg C, et al. Among authors: vanhoorelbeke k. Expert Rev Hematol. 2016;9(2):209-21. doi: 10.1586/17474086.2016.1122515. Epub 2015 Dec 8. Expert Rev Hematol. 2016. PMID: 26581428 Review.

5

Thrombotic thrombocytopenic pupura (TTP) dinner symposium proceedings.

Pavenski K, Cataland S, Kremer Hovinga J, Thomas M, Vanhoorelbeke K. Pavenski K, et al. Among authors: vanhoorelbeke k. Expert Rev Hematol. 2016 Aug;9(8):733-5. doi: 10.1080/17474086.2016.1198895. Epub 2016 Jun 22. Expert Rev Hematol. 2016. PMID: 27269186

6

Understanding therapeutic targets in thrombotic thrombocytopenic purpura.

Joly BS, Vanhoorelbeke K, Veyradier A. Joly BS, et al. Among authors: vanhoorelbeke k. Intensive Care Med. 2017 Sep;43(9):1398-1400. doi: 10.1007/s00134-016-4662-3. Epub 2017 Jan 23. Intensive Care Med. 2017. PMID: 28116452 No abstract available.

7

Thrombotic thrombocytopenic purpura.

Kremer Hovinga JA, Coppo P, Lämmle B, Moake JL, Miyata T, Vanhoorelbeke K. Kremer Hovinga JA, et al. Among authors: vanhoorelbeke k. Nat Rev Dis Primers. 2017 Apr 6;3:17020. doi: 10.1038/nrdp.2017.20. Nat Rev Dis Primers. 2017. PMID: 28382967 Review.

8

Amplified endogenous plasmin activity resolves acute thrombotic thrombocytopenic purpura in mice.

Tersteeg C, Joly BS, Gils A, Lijnen R, Deckmyn H, Declerck PJ, Plaimauer B, Coppo P, Veyradier A, Maas C, De Meyer SF, Vanhoorelbeke K. Tersteeg C, et al. Among authors: vanhoorelbeke k. J Thromb Haemost. 2017 Dec;15(12):2432-2442. doi: 10.1111/jth.13859. Epub 2017 Oct 27. J Thromb Haemost. 2017. PMID: 28981198 Free article.

9

An open conformation of ADAMTS-13 is a hallmark of acute acquired thrombotic thrombocytopenic purpura.

Roose E, Schelpe AS, Joly BS, Peetermans M, Verhamme P, Voorberg J, Greinacher A, Deckmyn H, De Meyer SF, Coppo P, Veyradier A, Vanhoorelbeke K. Roose E, et al. Among authors: vanhoorelbeke k. J Thromb Haemost. 2018 Feb;16(2):378-388. doi: 10.1111/jth.13922. Epub 2018 Jan 23. J Thromb Haemost. 2018. PMID: 29222940 Free article.

10

Insights into 3D Structure of ADAMTS13: A Stepping Stone towards Novel Therapeutic Treatment of Thrombotic Thrombocytopenic Purpura.

Ercig B, Wichapong K, Reutelingsperger CPM, Vanhoorelbeke K, Voorberg J, Nicolaes GAF. Ercig B, et al. Among authors: vanhoorelbeke k. Thromb Haemost. 2018 Jan;118(1):28-41. doi: 10.1160/TH17-06-0404. Epub 2018 Jan 5. Thromb Haemost. 2018. PMID: 29304523 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

212 results

Search Page